Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links?

Current Hypertension Reports - United States
doi 10.1007/s11906-013-0395-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Changes of Placental Syndecan-1 Expression in Preeclampsia and HELLP Syndrome

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2013English

Increased Maternal and Fetal Cholesterol Efflux Capacity and Placental CYP27A1 Expression in Preeclampsia

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2017English

Comparison of Perinatal and Maternal Outcomes of Severe Preeclampsia, Eclampsia, and HELLP Syndrome

Journal of the Turkish German Gynecology Association
GynecologyObstetrics
2011English

Placental Expression of Erythropoietin in Preeclampsia

Rossiiskii vestnik akushera-ginekologa
2015English

Placental Trophoblast Debris Mediated Feto-Maternal Signalling via Small RNA Delivery: Implications for Preeclampsia

Scientific Reports
Multidisciplinary
2017English

Figure 4: Placental Perlecan Expression in Preeclampsia With or Without HELLP Syndrome.

English

Intergenerational Factors: A Missing Link for Preeclampsia, Fetal Growth Restriction, and Cardiovascular Disease?

Hypertension
Internal Medicine
2008English

Placental Location and Development of Preeclampsia: A Longitudinal Study

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2019English

Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy